Cargando…
Itaconate confers tolerance to late NLRP3 inflammasome activation
Itaconate is a unique regulatory metabolite that is induced upon Toll-like receptor (TLR) stimulation in myeloid cells. Here, we demonstrate major inflammatory tolerance and cell death phenotypes associated with itaconate production in activated macrophages. We show that endogenous itaconate is a ke...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039864/ https://www.ncbi.nlm.nih.gov/pubmed/33691097 http://dx.doi.org/10.1016/j.celrep.2021.108756 |
_version_ | 1783677683144589312 |
---|---|
author | Bambouskova, Monika Potuckova, Lucie Paulenda, Tomas Kerndl, Martina Mogilenko, Denis A. Lizotte, Kate Swain, Amanda Hayes, Sebastian Sheldon, Ryan D. Kim, Hyeryun Kapadnis, Unnati Ellis, Abigail E. Isaguirre, Christine Burdess, Samantha Laha, Anwesha Amarasinghe, Gaya K. Chubukov, Victor Roddy, Thomas P. Diamond, Michael S. Jones, Russell G. Simons, Donald M. Artyomov, Maxim N. |
author_facet | Bambouskova, Monika Potuckova, Lucie Paulenda, Tomas Kerndl, Martina Mogilenko, Denis A. Lizotte, Kate Swain, Amanda Hayes, Sebastian Sheldon, Ryan D. Kim, Hyeryun Kapadnis, Unnati Ellis, Abigail E. Isaguirre, Christine Burdess, Samantha Laha, Anwesha Amarasinghe, Gaya K. Chubukov, Victor Roddy, Thomas P. Diamond, Michael S. Jones, Russell G. Simons, Donald M. Artyomov, Maxim N. |
author_sort | Bambouskova, Monika |
collection | PubMed |
description | Itaconate is a unique regulatory metabolite that is induced upon Toll-like receptor (TLR) stimulation in myeloid cells. Here, we demonstrate major inflammatory tolerance and cell death phenotypes associated with itaconate production in activated macrophages. We show that endogenous itaconate is a key regulator of the signal 2 of NLR family pyrin domain containing 3 (NLRP3) inflammasome activation after long lipopolysaccharide (LPS) priming, which establishes tolerance to late NLRP3 inflammasome activation. We show that itaconate acts synergistically with inducible nitric oxide synthase (iNOS) and that the ability of various TLR ligands to establish NLRP3 inflammasome tolerance depends on the pattern of co-expression of IRG1 and iNOS. Mechanistically, itaconate accumulation upon prolonged inflammatory stimulation prevents full caspase-1 activation and processing of gasdermin D, which we demonstrate to be post-translationally modified by endogenous itaconate. Altogether, our data demonstrate that metabolic rewiring in inflammatory macrophages establishes tolerance to NLRP3 inflammasome activation that, if uncontrolled, can result in pyroptotic cell death and tissue damage. |
format | Online Article Text |
id | pubmed-8039864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-80398642021-04-12 Itaconate confers tolerance to late NLRP3 inflammasome activation Bambouskova, Monika Potuckova, Lucie Paulenda, Tomas Kerndl, Martina Mogilenko, Denis A. Lizotte, Kate Swain, Amanda Hayes, Sebastian Sheldon, Ryan D. Kim, Hyeryun Kapadnis, Unnati Ellis, Abigail E. Isaguirre, Christine Burdess, Samantha Laha, Anwesha Amarasinghe, Gaya K. Chubukov, Victor Roddy, Thomas P. Diamond, Michael S. Jones, Russell G. Simons, Donald M. Artyomov, Maxim N. Cell Rep Article Itaconate is a unique regulatory metabolite that is induced upon Toll-like receptor (TLR) stimulation in myeloid cells. Here, we demonstrate major inflammatory tolerance and cell death phenotypes associated with itaconate production in activated macrophages. We show that endogenous itaconate is a key regulator of the signal 2 of NLR family pyrin domain containing 3 (NLRP3) inflammasome activation after long lipopolysaccharide (LPS) priming, which establishes tolerance to late NLRP3 inflammasome activation. We show that itaconate acts synergistically with inducible nitric oxide synthase (iNOS) and that the ability of various TLR ligands to establish NLRP3 inflammasome tolerance depends on the pattern of co-expression of IRG1 and iNOS. Mechanistically, itaconate accumulation upon prolonged inflammatory stimulation prevents full caspase-1 activation and processing of gasdermin D, which we demonstrate to be post-translationally modified by endogenous itaconate. Altogether, our data demonstrate that metabolic rewiring in inflammatory macrophages establishes tolerance to NLRP3 inflammasome activation that, if uncontrolled, can result in pyroptotic cell death and tissue damage. 2021-03-09 /pmc/articles/PMC8039864/ /pubmed/33691097 http://dx.doi.org/10.1016/j.celrep.2021.108756 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Bambouskova, Monika Potuckova, Lucie Paulenda, Tomas Kerndl, Martina Mogilenko, Denis A. Lizotte, Kate Swain, Amanda Hayes, Sebastian Sheldon, Ryan D. Kim, Hyeryun Kapadnis, Unnati Ellis, Abigail E. Isaguirre, Christine Burdess, Samantha Laha, Anwesha Amarasinghe, Gaya K. Chubukov, Victor Roddy, Thomas P. Diamond, Michael S. Jones, Russell G. Simons, Donald M. Artyomov, Maxim N. Itaconate confers tolerance to late NLRP3 inflammasome activation |
title | Itaconate confers tolerance to late NLRP3 inflammasome activation |
title_full | Itaconate confers tolerance to late NLRP3 inflammasome activation |
title_fullStr | Itaconate confers tolerance to late NLRP3 inflammasome activation |
title_full_unstemmed | Itaconate confers tolerance to late NLRP3 inflammasome activation |
title_short | Itaconate confers tolerance to late NLRP3 inflammasome activation |
title_sort | itaconate confers tolerance to late nlrp3 inflammasome activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039864/ https://www.ncbi.nlm.nih.gov/pubmed/33691097 http://dx.doi.org/10.1016/j.celrep.2021.108756 |
work_keys_str_mv | AT bambouskovamonika itaconateconferstolerancetolatenlrp3inflammasomeactivation AT potuckovalucie itaconateconferstolerancetolatenlrp3inflammasomeactivation AT paulendatomas itaconateconferstolerancetolatenlrp3inflammasomeactivation AT kerndlmartina itaconateconferstolerancetolatenlrp3inflammasomeactivation AT mogilenkodenisa itaconateconferstolerancetolatenlrp3inflammasomeactivation AT lizottekate itaconateconferstolerancetolatenlrp3inflammasomeactivation AT swainamanda itaconateconferstolerancetolatenlrp3inflammasomeactivation AT hayessebastian itaconateconferstolerancetolatenlrp3inflammasomeactivation AT sheldonryand itaconateconferstolerancetolatenlrp3inflammasomeactivation AT kimhyeryun itaconateconferstolerancetolatenlrp3inflammasomeactivation AT kapadnisunnati itaconateconferstolerancetolatenlrp3inflammasomeactivation AT ellisabigaile itaconateconferstolerancetolatenlrp3inflammasomeactivation AT isaguirrechristine itaconateconferstolerancetolatenlrp3inflammasomeactivation AT burdesssamantha itaconateconferstolerancetolatenlrp3inflammasomeactivation AT lahaanwesha itaconateconferstolerancetolatenlrp3inflammasomeactivation AT amarasinghegayak itaconateconferstolerancetolatenlrp3inflammasomeactivation AT chubukovvictor itaconateconferstolerancetolatenlrp3inflammasomeactivation AT roddythomasp itaconateconferstolerancetolatenlrp3inflammasomeactivation AT diamondmichaels itaconateconferstolerancetolatenlrp3inflammasomeactivation AT jonesrussellg itaconateconferstolerancetolatenlrp3inflammasomeactivation AT simonsdonaldm itaconateconferstolerancetolatenlrp3inflammasomeactivation AT artyomovmaximn itaconateconferstolerancetolatenlrp3inflammasomeactivation |